research day - University of Toronto Department of Obstetrics and ...

More documents

Recommendations

Info

68 ABSTRACT #P-F5 OUTCOMES IN ROBOTIC-ASSISTED SURGERY FOR GYNAECOLOGIC ONCOLOGY Lilian T Gien [F], Barry Rosen, Marcus Bernardini Division of Gynecologic Oncology, Princess Margaret Hospital, University of Toronto Objective: The purpose of this study was to analyze the perioperative and quality of life outcomes in patients with robotic-assisted surgery for gynaecologic oncology. Methods: In this prospective observational study, patients had robotic-assisted surgery consisting of a hysterectomy and bilateral salpingo-oophorectomy (HBSO) +/- omentectomy, pelvic and paraaortic node dissection between December 1, 2008 and February 23, 2009. All cases were done by two gynaecologic oncologists at a single institution. Data collection included operative time, estimated blood loss, intra- and post-operative complications, lymph node counts, and length of stay. The median operative time for the first half of patients was compared to that of the second half. Post-operative questionnaires were completed to evaluate pain control, return to normal activity, and quality of life. Statistical analysis included the Mann-Whitney U test. Results: Twenty gynaecologic oncology patients had robotic-assisted surgery. Median age was 63 years and median BMI was 32.7 kg/m 2 (range 20.8-57.9 kg/m 2 ). 85% had a malignancy, including endometrial, cervical or ovarian carcinoma. 50% of cases included pelvic and paraaortic lymphadenectomy; median lymph node count was 20. The median operative time was 203 mins (range 101-355 mins). Among those with HBSO +/- omentectomy, operative time significantly decreased between the first half and second half of patients (201 mins vs 124 mins, p=0.043). Conversion to a vaginal approach occurred in two patients. Five patients had minor postoperative complications such as UTI or genitofemoral nerve injury. Median estimated blood loss was 80 cc and median length of stay was 1 day. By 3 weeks after surgery, the majority of patients reported minimal to no pain, a return to normal activity, and a good quality of life. Conclusion: Robotic-assisted surgery is feasible in gynaecologic oncology patients who require surgical staging, and is associated with minimal blood loss, short hospital stay, and excellent patient recovery. As a tool for promoting minimally invasive surgery, increasing experience with the Da Vinci robotic system with even a small number of cases leads to a significant decrease in operative time.
69 ABSTRACT #P-G1 INCIDENCE OF GESTATIONAL HYPERTENSIVE DISORDERS IN PREGNANCIES COMPLICATED BY IUGR: TWINS VERSUS SINGLETONS Katy Gouin[F](1), Jon Barrett(1), Yoav Yinon(1), Ori Nevo(1). (1)Maternal-Fetal Medicine Division, Department of Obstetrics & Gynaecology, Sunnybrook Health Science Center, University of Toronto. Objective: To compare the incidence of gestational hypertensive disorders (GHD) in twin pregnancies complicated by intrauterine growth restriction (IUGR) to singleton IUGR pregnancies. Methods: A database and chart review of all pregnancies (twins and singletons) delivered at 23-41 weeks at a tertiary referral centre from July 2002 to 2007 was performed. Patients’ characteristics as well as birth weight, chorionicity and umbilical artery Doppler were collected. GHD included gestational hypertension and preeclampsia. IUGR was defined as birth weight ≤ 10 percentile using twin and singleton curves respectively. Chi-square and Student t test were used when appropriate. Results: 815 twin pregnancies and 16 666 singletons were delivered during the study period. 16.1% of twin pregnancies were complicated by IUGR of one twin (25% of them were monochorionic) compared to an incidence of 2.8% of IUGR in singleton pregnancies (p
Page 1:
Department of Obstetrics and Gynaec
Page 4 and 5:
2 PROGRAMME-AT-A-GLANCE (A.M.) 7:30
Page 7 and 8:
5 PROGRAMME 26TH ANNUAL RESEARCH DA
Page 9 and 10:
7 P-A4 PHENOTYPE OF EARLY ONSET INT
Page 11 and 12:
9 P-C2 ESTROGEN EXTRACTION FROM MIC
Page 13 and 14:
11 P-E4 LAPAROSCOPIC PERITONEAL ENT
Page 15 and 16:
13 12:05 - 1:05 p.m. LUNCH [Dining
Page 17 and 18:
15 P-G2 P16 ONCOPROTEIN AS A TRIAGE
Page 19 and 20: 17 GROUP I: Chairs/Judges: Drs. Jon
Page 21 and 22: 19 GROUP K: Chairs/Judges: Drs. Gra
Page 23 and 24: 21 4:15 - 5:15 p.m. Henderson Lectu
Page 25: 23 AWARDS The Papsin Award The Dr.
Page 28 and 29: 26 ABSTRACT #O1* CO-ENZYME Q10 SUPP
Page 30 and 31: 28 ABSTRACT #O3* VEPH1 IS A NOVEL R
Page 32 and 33: 30 ABSTRACT #O5* TISSUE SPECIFIC TR
Page 34 and 35: 32 ABSTRACT #O7 JOB SATISFACTION AM
Page 36 and 37: 34 ABSTRACT #O9 ABDOMINAL VISCERAL
Page 38 and 39: 36 ABSTRACT #O11 REGULATORY EFFECTS
Page 40 and 41: 38 ABSTRACT #O13 THE EFFECT OF CHRO
Page 42 and 43: POSTER ABSTRACTS 40
Page 44 and 45: 42 ABSTRACT #P-A2 INCREASED MATERNA
Page 46 and 47: 44 ABSTRACT #P-A4 PHENOTYPE OF EARL
Page 48 and 49: 46 ABSTRACT #P-B1* ANGIOGENIC CD56
Page 50 and 51: 48 ABSTRACT #P-B3 UNDERSTANDING THE
Page 52 and 53: 50 ABSTRACT #P-B5 LOW VITAMIN D LEV
Page 54 and 55: 52 ABSTRACT #P-C2* ESTROGEN EXTRACT
Page 56 and 57: 54 ABSTRACT #P-C4 PRETERM PERMATURE
Page 58 and 59: 56 ABSTRACT #P-D2 CRYOPRESERVATION
Page 60 and 61: 58 ABSTRACT #P-D4 DIFFERENTIAL EXPR
Page 62 and 63: 60 ABSTRACT #P-E1 THE ROLE OF ANDRO
Page 64 and 65: 62 ABSTRACT #P-E3 CELL CYCLE INHIBI
Page 66 and 67: 64 ABSTRACT #P-F1 DEXAMETHASONE STI
Page 68 and 69: 66 ABSTRACT #P-F3 EDUCATING SURGICA
Page 72 and 73: 70 ABSTRACT #P-G2 P16 ONCOPROTEIN A
Page 74 and 75: 72 ABSTRACT #P-G4 ALTERED ADRENOCOR
Page 76 and 77: 74 ABSTRACT #P-H1 RETINAL HEMORRHAG
Page 78 and 79: 76 ABSTRACT #P-H3 A ROLE FOR MCL-1
Page 80 and 81: 78 ABSTRACT #P-H5 A NOVEL ROLE FOR
Page 82 and 83: 80 ABSTRACT #P-I2 THE TIMING OF DEL
Page 84 and 85: 82 ABSTRACT #P-I4 OMEGA-3 FATTY ACI
Page 86 and 87: 84 ABSTRACT #P-J1* WHAT IS KEEPING
Page 88 and 89: 86 ABSTRACT #P-J3 HUMAN EMBRYONIC F
Page 90 and 91: 88 ABSTRACT #P-J5 BARRIERS TO COMPL
Page 92 and 93: 90 ABSTRACT #P-K2 THE “DUC” TRI
Page 94 and 95: 92 ABSTRACT #P-K4 IS THERE A ROLE F
Page 96 and 97: 94 ABSTRACT #P-L1 EXPRESSION AND RE
Page 98 and 99: 96 ABSTRACT #P-L3 IS ZONA PELLUCIDA
Page 100 and 101: 98 ABSTRACT #P-L5 SPECTRUM OF VASCU
Page 102 and 103: 100 Presenters by Last Name cont’
Page 104 and 105: 102 Presenters by Abstract # and Se
Page 106 and 107: 104 Presenters by Abstract # and Se
show all

research day - University of Toronto Department of Obstetrics and ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?